58 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 219,395 31,244 250,639 183,662 23,956 207,618 43,021 35,733 3 3 3 xbrli:pure xbrli:shares iso4217:GBP 08866941 2024-01-01 2024-12-31 08866941 2024-12-31 08866941 2023-12-31 08866941 2023-01-01 2023-12-31 08866941 2023-12-31 08866941 2022-12-31 08866941 core:NetGoodwill 2024-01-01 2024-12-31 08866941 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 08866941 core:PatentsTrademarksLicencesConcessionsSimilar 2024-01-01 2024-12-31 08866941 bus:Director1 2024-01-01 2024-12-31 08866941 core:NetGoodwill 2023-12-31 08866941 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 08866941 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 08866941 core:NetGoodwill 2024-12-31 08866941 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 08866941 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 08866941 core:AfterOneYear 2024-12-31 08866941 core:AfterOneYear 2023-12-31 08866941 core:WithinOneYear 2024-12-31 08866941 core:WithinOneYear 2023-12-31 08866941 core:ShareCapital 2024-12-31 08866941 core:ShareCapital 2023-12-31 08866941 core:SharePremium 2024-12-31 08866941 core:SharePremium 2023-12-31 08866941 core:RetainedEarningsAccumulatedLosses 2024-12-31 08866941 core:RetainedEarningsAccumulatedLosses 2023-12-31 08866941 core:NetGoodwill 2023-12-31 08866941 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 08866941 core:Non-currentFinancialInstruments 2024-12-31 08866941 core:Non-currentFinancialInstruments 2023-12-31 08866941 bus:SmallEntities 2024-01-01 2024-12-31 08866941 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08866941 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08866941 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08866941 bus:FullAccounts 2024-01-01 2024-12-31 08866941 core:PlantMachinery 2024-01-01 2024-12-31 08866941 core:PlantMachinery 2023-12-31 08866941 core:PlantMachinery 2024-12-31
COMPANY REGISTRATION NUMBER: 08866941
Check4Cancer Limited
Filleted Unaudited Financial Statements
For the year ended
31 December 2024
Check4Cancer Limited
Statement of Financial Position
31 December 2024
2024
2023
Note
£
£
£
£
Fixed assets
Intangible assets
5
207,690
12,845
Tangible assets
6
43,021
35,733
Investments
7
3
3
---------
--------
250,714
48,581
Current assets
Stocks
5,251
5,433
Debtors
8
803,248
931,592
Cash at bank and in hand
1,877,079
1,635,615
------------
------------
2,685,578
2,572,640
Creditors: amounts falling due within one year
9
1,611,412
1,565,799
------------
------------
Net current assets
1,074,166
1,006,841
------------
------------
Total assets less current liabilities
1,324,880
1,055,422
Creditors: amounts falling due after more than one year
10
7,887
18,201
------------
------------
Net assets
1,316,993
1,037,221
------------
------------
Capital and reserves
Called up share capital
435
435
Share premium account
1,874,768
1,874,768
Profit and loss account
( 558,210)
( 837,982)
------------
------------
Shareholders funds
1,316,993
1,037,221
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Check4Cancer Limited
Statement of Financial Position (continued)
31 December 2024
These financial statements were approved by the board of directors and authorised for issue on 26 September 2025 , and are signed on behalf of the board by:
L Lander
Director
Company registration number: 08866941
Check4Cancer Limited
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lower Court 3-4, Copley Hill Business Park, Cambridge Road, Cambridge, CB22 3GN, UK.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. Consolidation The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group. Revenue recognition Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably. When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period. When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable. Income tax The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Operating leases Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis. Intangible assets Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
5% straight line
Website
-
33% straight line
Patents
-
20% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
25% straight line
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 58 (2023: 50 ).
5. Intangible assets
Goodwill
Website
Patents
Total
£
£
£
£
Cost
At 1 January 2024
25,690
155,525
105,125
286,340
Additions
207,303
207,303
--------
---------
---------
---------
At 31 December 2024
25,690
362,828
105,125
493,643
--------
---------
---------
---------
Amortisation
At 1 January 2024
12,845
155,525
105,125
273,495
Charge for the year
1,284
11,174
12,458
--------
---------
---------
---------
At 31 December 2024
14,129
166,699
105,125
285,953
--------
---------
---------
---------
Carrying amount
At 31 December 2024
11,561
196,129
207,690
--------
---------
---------
---------
At 31 December 2023
12,845
12,845
--------
---------
---------
---------
6. Tangible assets
Plant and machinery
£
Cost
At 1 January 2024
219,395
Additions
31,244
---------
At 31 December 2024
250,639
---------
Depreciation
At 1 January 2024
183,662
Charge for the year
23,956
---------
At 31 December 2024
207,618
---------
Carrying amount
At 31 December 2024
43,021
---------
At 31 December 2023
35,733
---------
7. Investments
Shares in group undertakings
£
Cost
At 1 January 2024 and 31 December 2024
3
----
Impairment
At 1 January 2024 and 31 December 2024
----
Carrying amount
At 31 December 2024
3
----
At 31 December 2023
3
----
8. Debtors
2024
2023
£
£
Trade debtors
208,473
290,607
Amounts owed by group undertakings and undertakings in which the company has a participating interest
328,546
295,882
Other debtors
266,229
345,103
---------
---------
803,248
931,592
---------
---------
The debtors above include the following amounts falling due after more than one year:
2024
2023
£
£
Amounts owed by group undertakings and undertakings in which the company has a participating interest
328,546
295,882
Other debtors
7,000
7,000
---------
---------
335,546
302,882
---------
---------
9. Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
10,311
47,097
Trade creditors
444,490
285,132
Social security and other taxes
64,444
51,790
Other creditors
1,092,167
1,181,780
------------
------------
1,611,412
1,565,799
------------
------------
Loans totalling £nil (2023 - £37,040) are secured by means of fixed and floating charges over the assets of the company.
10. Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
7,887
18,201
-------
--------
11. Operating leases
The total future minimum lease payments under non-cancellable operating leases are as follows:
2024
2023
£
£
Not later than 1 year
38,000
38,000
--------
--------